Biorem Inc. (V:BRM)
Business Focus: Purification & Treatment Equipment
Apr 11, 2024 11:20 am ET
Biorem Reports 2023 Financial Results including $0.14 earnings per share
GUELPH, ON, April 11, 2024 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2023. Biorem's complete fiscal 2023 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Nov 29, 2023 07:00 am ET
Biorem Reports Third Quarter Results, Record Order Backlog and Quarterly EPS of $0.03
GUELPH, ON, Nov. 29, 2023 /CNW/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "The Company") today announced its results for the three and nine-month periods ended September 30, 2023. BIOREM's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Aug 23, 2023 08:00 am ET
Biorem Reports Second Quarter Results and Record Order Backlog
GUELPH, ON, Aug. 23, 2023 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2023. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Jun 09, 2023 08:00 am ET
Biorem Announces Stock Option Grant
GUELPH, ON, June 9, 2023 /CNW/ - Biorem Inc. (TSXV: BRM) ("Biorem", or "the Company") announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors, of the Company to purchase up to an aggregate of 50,000 common shares in the capital stock of the Company. The options are exercisable at a price of $1.01 per share for a period of ten years from the date of grant.
Jun 09, 2023 08:00 am ET
Biorem Announces Stock Option Grant
GUELPH, ON, June 9, 2023 /PRNewswire/ - Biorem Inc. (TSXV: BRM) ("Biorem", or "the Company") announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors, of the Company to purchase up to an aggregate of 50,000 common shares in the capital stock of the Company. The options are exercisable at a price of $1.01 per share for a period of ten years from the date of grant.
Jun 06, 2023 08:00 am ET
BIOREM order backlog exceeds $50 million on strength of $11-million in new orders
North American sales a "vote of confidence" in new technologies and growth initiatives
Jun 06, 2023 08:00 am ET
BIOREM order backlog exceeds $50 million on strength of $11-million in new orders
North American sales a "vote of confidence" in new technologies and growth initiatives
May 24, 2023 08:00 am ET
Biorem Reports First Quarter Financial Results
GUELPH, ON, May 24, 2023 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2023. Biorem's complete 2023 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
May 24, 2023 08:00 am ET
Biorem Reports First Quarter Financial Results
GUELPH, ON, May 24, 2023 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2023. Biorem's complete 2023 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Apr 05, 2023 08:00 am ET
Biorem Reports Record 2022 Financial Results
GUELPH, ON, April 5, 2023 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2022. Biorem's complete fiscal 2022 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Apr 05, 2023 08:00 am ET
Biorem Reports Record 2022 Financial Results
GUELPH, ON, April 5, 2023 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2022. Biorem's complete fiscal 2022 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Nov 15, 2022 07:00 am ET
Biorem Reports Third Quarter Results & Increases in Revenues and Earnings
GUELPH, ON, Nov. 15, 2022 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2022. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Nov 15, 2022 07:00 am ET
Biorem Reports Third Quarter Results & Increases in Revenues and Earnings
GUELPH, ON, Nov. 15, 2022 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2022. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Oct 05, 2022 08:00 am ET
New growth initiatives drive BIOREM order backlog to record $44.5M
Recent North American sales of $7.1M seen as "vote in confidence" in new product and services
Oct 05, 2022 08:00 am ET
New growth initiatives drive BIOREM order backlog to record $44.5M
Recent North American sales of $7.1M seen as "vote in confidence" in new product and services
Aug 23, 2022 08:00 am ET
Biorem Reports Second Quarter Results & Record Order Backlog
GUELPH, ON, Aug. 23, 2022 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2022. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Aug 23, 2022 08:00 am ET
Biorem Reports Second Quarter Results & Record Order Backlog
GUELPH, ON, Aug. 23, 2022 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2022. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Jun 07, 2022 08:30 am ET
BIOREM order backlog grows to $40-million on strength of $11-million in new orders
North American sales a "vote of confidence" in new technologies, approach
Jun 07, 2022 08:30 am ET
BIOREM order backlog grows to $40-million on strength of $11-million in new orders
North American sales a "vote of confidence" in new technologies, approach
May 20, 2022 08:00 am ET
Biorem Reports First Quarter Financial Results
GUELPH, ON, May 20, 2022 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2022. Biorem's complete 2022 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
May 20, 2022 08:00 am ET
Biorem Reports First Quarter Financial Results
GUELPH, ON, May 20, 2022 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2022. Biorem's complete 2022 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Mar 30, 2022 04:30 pm ET
BIOREM Announces Stock Option Grant
GUELPH, ON, March 30, 2022 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem", or "the Company") announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors, officers and employees of the Company to purchase up to an aggregate of 850,000 common shares in the capital stock of the Company. The options are exercisable at a price of $0.81 per share for a period of ten years from the date of grant.
Mar 28, 2022 04:30 pm ET
Biorem Reports 2021 Financial Results
GUELPH, ON, March 28, 2022 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2021. Biorem's complete fiscal 2021 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Mar 28, 2022 04:30 pm ET
Biorem Reports 2021 Financial Results
GUELPH, ON, March 28, 2022 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2021. Biorem's complete fiscal 2021 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Dec 02, 2021 07:30 am ET
BIOREM Announces Closing of Transaction to Purchase Common Shares for Cancellation
GUELPH, ON, Dec. 2, 2021 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") is pleased to announce that it has completed the transaction to purchase for cancellation 23,434,121 common shares at $0.5256 per common share from TPFG Environment Investment Limited ("TPFG") for an aggregate purchase price of $12,316,974 (the "Share Repurchase").
Dec 02, 2021 07:30 am ET
BIOREM Announces Closing of Transaction to Purchase Common Shares for Cancellation
GUELPH, ON, Dec. 2, 2021 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") is pleased to announce that it has completed the transaction to purchase for cancellation 23,434,121 common shares at $0.5256 per common share from TPFG Environment Investment Limited ("TPFG") for an aggregate purchase price of $12,316,974 (the "Share Repurchase").
Nov 25, 2021 06:45 am ET
BIOREM Reports Third Quarter 2021 Financial Results
GUELPH, ON, Nov. 25, 2021 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2021. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Nov 25, 2021 06:45 am ET
BIOREM Reports Third Quarter 2021 Financial Results
GUELPH, ON, Nov. 25, 2021 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2021. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Nov 17, 2021 07:00 am ET
BIOREM Announces the Novel Application of its Biological Reactors to a New Market Segment
GUELPH, ON, Nov. 17, 2021 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced a new order for an advanced biological system to address gaseous emissions from a Natural Organic Reduction (NOR) facility.
Nov 17, 2021 07:00 am ET
BIOREM Announces the Novel Application of its Biological Reactors to a New Market Segment
GUELPH, ON, Nov. 17, 2021 /CNW/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced a new order for an advanced biological system to address gaseous emissions from a Natural Organic Reduction (NOR) facility.
Sep 17, 2021 08:00 am ET
Biorem Shareholders Approve Purchase for Cancellation of Common Shares Held by TPFG Environment Investment Limited
GUELPH, ON, Sept. 17, 2021 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced that at the special meeting of shareholders held on September 16, 2021 the shareholders approved the purchase for cancellation of 23,434,121 common shares of the Company from TPFG Environment Investment Limited ("TPFG").
Sep 17, 2021 08:00 am ET
Biorem Shareholders Approve Purchase for Cancellation of Common Shares Held by TPFG Environment Investment Limited
GUELPH, ON, Sept. 17, 2021 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced that at the special meeting of shareholders held on September 16, 2021 the shareholders approved the purchase for cancellation of 23,434,121 common shares of the Company from TPFG Environment Investment Limited ("TPFG").
Aug 05, 2021 08:00 am ET
BIOREM Announces Proposed Purchase for Cancellation of Common Shares Held by TPFG Environment Investment Limited
GUELPH, ON, Aug. 5, 2021 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced that its independent directors have approved, subject to regulatory and disinterested shareholder approval, the purchase for cancellation of 23,434,121 common shares at $0.5256 per common share from TPFG Environment Investment Limited ("TPFG") for an aggregate purchase price of $12,316,974 (the "Share Repurchase"). Mr. Ken Chen and Ms. Wei Han, who are both directors of Biorem and employees of affiliates of TPFG recused themselves from all board discussions in respect of the Share Repurchase
Aug 05, 2021 08:00 am ET
BIOREM Announces Proposed Purchase for Cancellation of Common Shares Held by TPFG Environment Investment Limited
GUELPH, ON, Aug. 5, 2021 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced that its independent directors have approved, subject to regulatory and disinterested shareholder approval, the purchase for cancellation of 23,434,121 common shares at $0.5256 per common share from TPFG Environment Investment Limited ("TPFG") for an aggregate purchase price of $12,316,974 (the "Share Repurchase"). Mr. Ken Chen and Ms. Wei Han, who are both directors of Biorem and employees of affiliates of TPFG recused themselves from all board discussions in respect of the Share Rep
Jul 28, 2021 08:00 am ET
BIOREM Reports Second Quarter 2021 Financial Results
GUELPH, ON, July 28, 2021 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2021. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Jul 28, 2021 08:00 am ET
BIOREM Reports Second Quarter 2021 Financial Results
GUELPH, ON, July 28, 2021 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2021. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
May 19, 2021 08:00 am ET
BIOREM Reports First Quarter 2021 Financial Results
GUELPH, ON, May 19, 2021 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2021. Biorem's complete 2021 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Mar 31, 2021 08:00 am ET
Biorem Reports $2.1 million Earnings for Fiscal 2020
GUELPH, ON, March 31, 2021 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2020. Biorem's complete fiscal 2020 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Dec 14, 2020 07:00 am ET
BIOREM Announces Research Project with City of New York to Control Release of Bioaerosols from Waste Water Treatment Facilities
GUELPH, ON, Dec. 14, 2020 /CNW/ – BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced a research project in collaboration with the City of New York to examine the efficacy of BIOREM's enhanced biological processes for the mitigation of odours and hazardous air pollutants from various wastewater treatment facilities under their operation. A key component of the research and demonstration project will be to look at the effectiveness of BIOREM's systems to reduce or eliminate the transmission of bioaerosols from these emissions.
Dec 14, 2020 07:00 am ET
BIOREM Announces Research Project with City of New York to Control Release of Bioaerosols from Waste Water Treatment Facilities
GUELPH, ON, Dec. 14, 2020 /PRNewswire/ – BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced a research project in collaboration with the City of New York to examine the efficacy of BIOREM's enhanced biological processes for the mitigation of odours and hazardous air pollutants from various wastewater treatment facilities under their operation. A key component of the research and demonstration project will be to look at the effectiveness of BIOREM's systems to reduce or eliminate the transmission of bioaerosols from these emissions.
Dec 08, 2020 07:00 am ET
BIOREM Announces Successful Demonstration Projects Assessing Novel Biological Processes for the Mitigation of Industrial VOC Emissions
GUELPH, ON, Dec. 8, 2020 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced the successful completion of two research projects for the mitigation of volatile organic compounds from complex industrial gas emissions. Both projects were to assess and compare the efficacy of BIOREM's enhanced biological processes against legacy abatement technologies.
Dec 08, 2020 07:00 am ET
BIOREM Announces Successful Demonstration Projects Assessing Novel Biological Processes for the Mitigation of Industrial VOC Emissions
GUELPH, ON, Dec. 8, 2020 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced the successful completion of two research projects for the mitigation of volatile organic compounds from complex industrial gas emissions. Both projects were to assess and compare the efficacy of BIOREM's enhanced biological processes against legacy abatement technologies.
Nov 25, 2020 07:00 am ET
BIOREM Reports 2020 Third Quarter Results
GUELPH, ON, Nov. 25, 2020 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2020. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Nov 25, 2020 07:00 am ET
BIOREM Reports 2020 Third Quarter Results
GUELPH, ON, Nov. 25, 2020 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2020. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Nov 16, 2020 02:18 pm ET
IIROC Trading Resumption - BRM
VANCOUVER, BC, Nov. 16, 2020 /CNW/ - Trading resumes in:
Nov 16, 2020 01:04 pm ET
IIROC Trading Halt - BRM
VANCOUVER, BC, Nov. 16, 2020 /CNW/ - The following issues have been halted by IIROC:
Nov 16, 2020 12:35 pm ET
BIOREM Announces Several Orders Totalling $10.8 Million and Order Backlog of $35.6 Million
GUELPH, ON, Nov. 16, 2020 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced a number of new orders totalling $10.8 million. The orders are for air emission abatement projects in China and North America.
Aug 11, 2020 08:00 am ET
BIOREM Reports 2020 Second Quarter Results
GUELPH, ON, Aug. 11, 2020 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2020. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Jun 24, 2020 05:31 pm ET
Biorem Reports First Quarter Financial Results
GUELPH, ON, June 24, 2020 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2020. Biorem's complete 2020 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
May 29, 2020 10:21 am ET
BIOREM Announces Delay in Filing Interim Financial Statements
GUELPH, ON, May 29 2020 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("BIOREM" or "the Company") announces that due to circumstances created by the Covid-19 pandemic, it will be postponing its reporting of the Company's interim consolidated financial statements, accompanying management's discussion and analysis, and related CEO and CFO certifications for the three months ended March 31, 2020 (the "First Quarter Filings"), required to be filed by May 29, 2020 pursuant to National Instrument 51-102 - Continuous Disclosure Obligations ("NI 51-102").
May 08, 2020 04:00 pm ET
BIOREM Reports 2019 Financial Results
GUELPH, ON, May 8, 2020 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2019. Biorem's complete fiscal 2019 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Apr 29, 2020 03:05 pm ET
BIOREM Announces Delay in Filing Annual Financial Statements
GUELPH, ON, April 29, 2020 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("BIOREM" or "the Company") announces that due to circumstances created by the Covid-19 pandemic, it will be postponing its reporting of the Company's audited financial statements, accompanying management's discussion and analysis, and related CEO and CFO certifications for the year ended December 31, 2019 (the "Annual Filings"), required to be filed by April 29, 2020 pursuant to National Instrument 51-102 - Continuous Disclosure Obligations ("NI 51-102").
Jan 20, 2020 07:15 am ET
BIOREM Announces Joint Venture in China
GUELPH, ON, Jan. 20, 2020 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced the establishment of Zhongjia Clean Technology (Wuhu) Co., Ltd ("Zhongjia") a joint venture in Anhui Province, People's Republic of China with Tus Qingyuan (Beijing) Si-Tech Co., Ltd ("Qingyuan"). The joint venture is another phase in BIOREM's growth and development strategy for the country.
Dec 16, 2019 09:02 am ET
BIOREM Announces Order with City of Montreal totalling $6 Million and a backlog of $33 Million
GUELPH, ON, Dec. 16, 2019 /CNW/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced a new order totalling $6 million. The order is for an air emission abatement project in Montreal Quebec.
Dec 09, 2019 10:33 am ET
BIOREM Announces New Orders totalling $5.7 Million and Continued China Expansion
GUELPH, ON, Dec. 9, 2019 /CNW/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced new orders totalling $5.7 million. The orders are for air emission abatement projects in China and North America.
Nov 20, 2019 06:55 am ET
Biorem Reports Third Quarter 2019 Financial Results
GUELPH, ON, Nov. 20, 2019 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced results for the three and nine-month periods ended September 30, 2019. Biorem's complete 2019 third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Aug 29, 2019 06:41 pm ET
Biorem Reports Second Quarter Results
GUELPH, ON, Aug. 29, 2019 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2019. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
May 29, 2019 08:00 am ET
BIOREM Reports First Quarter 2019 Financial Results
GUELPH, ON, May 29, 2019 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2019. Biorem's complete 2019 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Mar 18, 2019 11:00 am ET
BIOREM Reports 8% Increase in Revenue, Earnings of $4.7 million and EPS of $0.12
GUELPH, ON, March 18, 2019 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("BIOREM" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2018. BIOREM's complete fiscal 2018 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Mar 18, 2019 11:00 am ET
BIOREM Reports 8% Increase in Revenue, Earnings of $4.7 million and EPS of $0.12
GUELPH, ON, March 18, 2019 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("BIOREM" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2018. BIOREM's complete fiscal 2018 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Feb 14, 2019 11:04 am ET
BIOREM Announces International Expansion of Distribution Network
GUELPH, ON, Feb. 14, 2019 /CNW/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced distribution expansion into two new geographic areas. The expansion is part of a concerted global sales growth initiative.
Feb 14, 2019 11:04 am ET
BIOREM Announces International Expansion of Distribution Network
GUELPH, ON, Feb. 14, 2019 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced distribution expansion into two new geographic areas. The expansion is part of a concerted global sales growth initiative.
Jan 23, 2019 01:18 pm ET
BIOREM Announces Orders Totalling $3.6 Million
GUELPH, ON, Jan. 23, 2019 /CNW/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced two new orders totalling $3.6 million. The orders are for air emission abatement projects in China and North America.
Jan 23, 2019 01:18 pm ET
BIOREM Announces Orders Totalling $3.6 Million
GUELPH, ON, Jan. 23, 2019 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced two new orders totalling $3.6 million. The orders are for air emission abatement projects in China and North America.
Nov 07, 2018 07:00 am ET
BIOREM Reports Third Quarter 2018 Financial Results
GUELPH, ON, Nov. 7, 2018 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2018. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Nov 07, 2018 07:00 am ET
BIOREM Reports Third Quarter 2018 Financial Results
GUELPH, ON, Nov. 7, 2018 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2018. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Aug 28, 2018 07:45 am ET
BIOREM Reports Second Quarter 2018 Financial Results
GUELPH, ON, Aug. 28, 2018 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2018. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Aug 28, 2018 07:45 am ET
BIOREM Reports Second Quarter 2018 Financial Results
GUELPH, ON, Aug. 28, 2018 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2018. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Aug 13, 2018 08:00 am ET
BIOREM Announces Orders Totalling $12.2 million - Including $4 million in China
GUELPH, ON, Aug. 13, 2018 /CNW/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced a number of new orders totalling $12.2 million. The orders are for air emission abatement projects in North America and China. The new orders include 15 new contracts in Canada and the USA totalling $8.2M and 4 new contracts in China totaling $4.0M. All of these contracts represent orders for custom designed, advanced biological air and gas emissions abatement equipment for delivery within 2018 and early 2019.
Aug 13, 2018 08:00 am ET
BIOREM Announces Orders Totalling $12.2 million - Including $4 million in China
GUELPH, ON, Aug. 13, 2018 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced a number of new orders totalling $12.2 million. The orders are for air emission abatement projects in North America and China. The new orders include 15 new contracts in Canada and the USA totalling $8.2M and 4 new contracts in China totaling $4.0M. All of these contracts represent orders for custom designed, advanced biological air and gas emissions abatement equipment for delivery within 2018 and early 2019.
Jul 11, 2018 12:38 pm ET
Biorem Announces Stock Option Grant
GUELPH, ON, July 11, 2018 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors, officers and employees of the Company to purchase up to an aggregate of 130,000 common shares in the capital stock of the Company. The options are exercisable at a price of $0.35 per share for a period of ten years from the date of grant.
Jul 11, 2018 12:38 pm ET
Biorem Announces Stock Option Grant
GUELPH, ON, July 11, 2018 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors, officers and employees of the Company to purchase up to an aggregate of 130,000 common shares in the capital stock of the Company. The options are exercisable at a price of $0.35 per share for a period of ten years from the date of grant.
May 15, 2018 01:45 pm ET
Biorem Reports First Quarter 2018 Financial Results
GUELPH, ON, May 15, 2018 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2018. Biorem's complete 2018 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
May 15, 2018 01:45 pm ET
Biorem Reports First Quarter 2018 Financial Results
GUELPH, ON, May 15, 2018 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2018. Biorem's complete 2018 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Mar 26, 2018 07:00 am ET
Biorem Reports 42% Increase in Revenue, Earnings of $1.5 million and EPS of $0.04
GUELPH, ON, March 26, 2018 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2017. Biorem's complete fiscal 2017 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Mar 26, 2018 07:00 am ET
Biorem Reports 42% Increase in Revenue, Earnings of $1.5 million and EPS of $0.04
GUELPH, ON, March 26, 2018 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2017. Biorem's complete fiscal 2017 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Mar 15, 2018 01:34 pm ET
BIOREM announces orders totalling $5.3 million
GUELPH, ON, March 15, 2018 /CNW/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced several new orders totalling $5.3 million. The orders are for air emission abatement projects in North America and Australia.
Mar 15, 2018 01:34 pm ET
BIOREM announces orders totalling $5.3 million
GUELPH, ON, March 15, 2018 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced several new orders totalling $5.3 million. The orders are for air emission abatement projects in North America and Australia.
Dec 13, 2017 06:30 am ET
BIOREM Announces Orders totalling $7.0 million and Order Backlog of $17 Million
GUELPH, ON, Dec. 13, 2017 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced several new orders totalling $7.0 million. The orders are for air emission abatement projects in China and North America.
Dec 13, 2017 06:30 am ET
BIOREM Announces Orders totalling $7.0 million and Order Backlog of $17 Million
GUELPH, ON, Dec. 13, 2017 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced several new orders totalling $7.0 million. The orders are for air emission abatement projects in China and North America.
Nov 15, 2017 07:30 am ET
BIOREM Reports Significant Revenue and Income Growth for Third Quarter
GUELPH, ON, Nov. 15, 2017 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2017. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Nov 15, 2017 07:30 am ET
BIOREM Reports Significant Revenue and Income Growth for Third Quarter
GUELPH, ON, Nov. 15, 2017 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2017. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Aug 30, 2017 12:54 pm ET
Biorem Reports Second Quarter 2017 Results
GUELPH, ON, Aug. 30, 2017 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced results for the three and six-month periods ended June 30, 2017. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Aug 30, 2017 12:54 pm ET
Biorem Reports Second Quarter 2017 Results
GUELPH, ON, Aug. 30, 2017 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced results for the three and six-month periods ended June 30, 2017. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Aug 10, 2017 03:00 pm ET
BIOREM Announces New Orders Totaling $5 Million
GUELPH, ON, Aug. 10, 2017 /CNW/ – BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several new orders totaling $5 million. The orders are for air emission abatement projects in North America, the Middle East and China.
Aug 10, 2017 03:00 pm ET
BIOREM Announces New Orders Totaling $5 Million
GUELPH, ON, Aug. 10, 2017 /PRNewswire/ – BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several new orders totaling $5 million. The orders are for air emission abatement projects in North America, the Middle East and China.
Jun 20, 2017 08:00 am ET
BIOREM Announces Strategic Partnership to Market Ultrafiltration Membranes
GUELPH, ON, June 20, 2017 /CNW/ – BIOREM Inc. (TSX-V: BRM) ("BIOREM" or "the Company") announces that it has entered into a strategic partnership with Tus-Material Group to market globally their ultrafiltration membranes.
Jun 05, 2017 08:00 am ET
BIOREM Announces Orders totalling $5.4 million and Order Backlog of $24 Million
GUELPH, ON, June 5, 2017 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several new orders totalling $5.4 million. The orders are for air emission abatement projects in North America.
Jun 05, 2017 08:00 am ET
BIOREM Announces Orders totalling $5.4 million and Order Backlog of $24 Million
GUELPH, ON, June 5, 2017 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several new orders totalling $5.4 million. The orders are for air emission abatement projects in North America.
May 18, 2017 12:27 pm ET
Biorem Reports First Quarter Financial Results
GUELPH, ON, May 18, 2017 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2017. Biorem's complete 2017 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
May 18, 2017 12:27 pm ET
Biorem Reports First Quarter Financial Results
GUELPH, ON, May 18, 2017 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2017. Biorem's complete 2017 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Apr 25, 2017 06:01 pm ET
Biorem Announces $3.1 Million in New Orders for the Company's Air Emissions Control Systems
GUELPH, ON, April 25, 2017 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company"), a leading global environmental technology company focused on air emissions control systems, today announced new orders totalling $3.1 million.
Apr 25, 2017 06:01 pm ET
Biorem Announces $3.1 Million in New Orders for the Company's Air Emissions Control Systems
GUELPH, ON, April 25, 2017 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company"), a leading global environmental technology company focused on air emissions control systems, today announced new orders totalling $3.1 million.
Apr 04, 2017 07:24 pm ET
BIOREM Reports $15.9 million Revenue and $0.04 EPS
GUELPH, ON, April 4, 2017 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2016. Biorem's complete fiscal 2016 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Apr 04, 2017 07:24 pm ET
BIOREM Reports $15.9 million Revenue and $0.04 EPS
GUELPH, ON, April 4, 2017 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2016. Biorem's complete fiscal 2016 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Feb 01, 2017 04:15 pm ET
BIOREM Announces New Orders Totalling $2.1 Million
GUELPH, ON, Feb. 1, 2017 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several new orders totalling $2.1 million. The orders are for air emission abatement projects in North America and Africa.
Feb 01, 2017 04:15 pm ET
BIOREM Announces New Orders Totalling $2.1 Million
GUELPH, ON, Feb. 1, 2017 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several new orders totalling $2.1 million. The orders are for air emission abatement projects in North America and Africa.
Jan 19, 2017 11:24 am ET
Biorem Reports Sale of Securities by Major Shareholders
GUELPH, ON, Jan. 19, 2017 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announced today that the sale of securities previously announced on June 24, 2016 by its major shareholders, Clean Technology Fund I, LP and Clean Technology Fund II, LP, United States based venture capital funds to TPFG Environment Investment Limited ("TUS") (en.tusholdings.com), has closed.
Jan 19, 2017 11:24 am ET
Biorem Reports Sale of Securities by Major Shareholders
GUELPH, ON, Jan. 19, 2017 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announced today that the sale of securities previously announced on June 24, 2016 by its major shareholders, Clean Technology Fund I, LP and Clean Technology Fund II, LP, United States based venture capital funds to TPFG Environment Investment Limited ("TUS") (en.tusholdings.com), has closed.
Nov 24, 2016 04:05 pm ET
BIOREM announces orders totalling $4.8 million
GUELPH, ON, Nov. 24, 2016 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several new orders totalling $4.8 million. The orders are for air emission abatement projects in North America, the Middle East and Asia.
Nov 24, 2016 04:05 pm ET
BIOREM announces orders totalling $4.8 million
GUELPH, ON, Nov. 24, 2016 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several new orders totalling $4.8 million. The orders are for air emission abatement projects in North America, the Middle East and Asia.
Nov 14, 2016 09:00 am ET
Biorem Reports Third Quarter Results and Net Earnings of $0.02 per share
GUELPH, ON, Nov. 14, 2016 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2016. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Nov 14, 2016 09:00 am ET
Biorem Reports Third Quarter Results and Net Earnings of $0.02 per share
GUELPH, ON, Nov. 14, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2016. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Jul 26, 2016 11:05 am ET
Biorem Reports Second Quarter Results
GUELPH, ON, July 26, 2016 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2016. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Jul 26, 2016 11:05 am ET
Biorem Reports Second Quarter Results
GUELPH, ON, July 26, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2016. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Jul 13, 2016 06:11 pm ET
Biorem Announces Issuance of Stock Options to Directors
GUELPH, ON, July 13, 2016 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced under its stock option plan that 60,000 options to purchase common shares of the Company have been issued to Directors of the Company. The options have an exercise price of $0.28 and vest over three years with a ten year expiry date of July 13, 2019.
Jul 13, 2016 06:11 pm ET
Biorem Announces Issuance of Stock Options to Directors
GUELPH, ON, July 13, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced under its stock option plan that 60,000 options to purchase common shares of the Company have been issued to Directors of the Company. The options have an exercise price of $0.28 and vest over three years with a ten year expiry date of July 13, 2019.
Jun 27, 2016 02:42 pm ET
Biorem Reports Sale of Securities by Major Shareholders
GUELPH, ON, June 27, 2016 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces that it has been advised by its major shareholders, Clean Technology Fund I, LP and Clean Technology Fund II, LP, United States based venture capital funds which together hold approximately 59% of the common shares of Biorem (on a fully diluted, as converted basis), that they have entered into an agreement for the disposition of their entire equity holdings in Biorem to TUS Holdings Co. Ltd. ("TUS") (en.tusholdings.com) at a purchase price equivalent to $0.345 per common share. Biorem understands
Jun 27, 2016 02:42 pm ET
Biorem Reports Sale of Securities by Major Shareholders
GUELPH, ON, June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces that it has been advised by its major shareholders, Clean Technology Fund I, LP and Clean Technology Fund II, LP, United States based venture capital funds which together hold approximately 59% of the common shares of Biorem (on a fully diluted, as converted basis), that they have entered into an agreement for the disposition of their entire equity holdings in Biorem to TUS Holdings Co. Ltd. ("TUS") (en.tusholdings.com) at a purchase price equivalent to $0.345 per common share. Biorem unde
May 19, 2016 03:12 pm ET
BIOREM Reports Increased Revenues and Earnings for First Quarter
GUELPH, ON, May 19, 2016 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2016. Biorem's complete 2016 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
May 19, 2016 03:12 pm ET
BIOREM Reports Increased Revenues and Earnings for First Quarter
GUELPH, ON, May 19, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2016. Biorem's complete 2016 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Apr 04, 2016 04:26 pm ET
BIOREM Reports 58% Year Over Year Increase in Revenue and $0.13 EPS
GUELPH, ON, April 4, 2016 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2015. Biorem's complete fiscal 2015 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Apr 04, 2016 04:26 pm ET
BIOREM Reports 58% Year Over Year Increase in Revenue and $0.13 EPS
GUELPH, ON, April 4, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2015. Biorem's complete fiscal 2015 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Mar 17, 2016 01:20 pm ET
BIOREM Responds to Statement of Claim
GUELPH, ON, March 17, 2016 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or the "Company") announces that it has been named, among others, as a defendant in a lawsuit issued in the Province of Ontario.
Mar 17, 2016 01:20 pm ET
BIOREM Responds to Statement of Claim
GUELPH, ON, March 17, 2016 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or the "Company") announces that it has been named, among others, as a defendant in a lawsuit issued in the Province of Ontario.
Feb 08, 2016 03:12 pm ET
BIOREM announces nomination to the TSX Venture 50 finalists
GUELPH, ON, Feb. 8, 2016 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced being nominated to the top ten finalists for clean technology companies in the TSX Venture 50TM.
Feb 08, 2016 03:12 pm ET
BIOREM announces nomination to the TSX Venture 50 finalists
GUELPH, ON, Feb. 8, 2016 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced being nominated to the top ten finalists for clean technology companies in the TSX Venture 50TM.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
